Rod Wong
Chairman at ROCKET PHARMACEUTICALS, INC.
Net worth: 39 M $ as of 2024-04-29
Network origin in Rod Wong first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York.
30
| Subsidiary | Investment Managers | 30 |
| Public Company | Biotechnology | 28 | |
| Public Company | Biotechnology | 13 | |
| Public Company | Biotechnology | 11 | |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.
10
| Extinct | Pharmaceuticals: Major | 10 |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds.
8
| Private Company | Investment Managers | 8 |
| Extinct | Financial Conglomerates | 7 | |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE.
5
| Holding Company | Biotechnology | 5 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rod Wong via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| New York University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Corporate Officer/Principal Private Equity Investor | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
HealthTronics, Inc.
 HealthTronics, Inc. Medical SpecialtiesHealth Technology HealthTronics, Inc. provides healthcare and technology support services. The firm focuses on urologist partnership opportunities, surgical and capital equipment maintenance and anatomical pathology services. Its products portfolio include urology devices, including lithotripters and surgical treatment lasers. The company was founded by Argil J. Wheelock in 1972 and is headquartered in Austin, TX. | Medical Specialties | Director/Board Member Director/Board Member | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
| Stephen M. Ross School of Business | College/University | Undergraduate Degree Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Deerfield Management Co. LP
 Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Investment Managers | Founder Analyst-Equity | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Indiana University | College/University | Undergraduate Degree Undergraduate Degree | |
| NUVASIVE, INC. | Medical Specialties | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
| Washington University in St. Louis | College/University | Doctorate Degree Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Investor Relations Contact Comptroller/Controller/Auditor | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director of Finance/CFO Investor Relations Contact | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chairman Chairman | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Founder Founder | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder Founder |
Statistics
International
| United States | 47 |
| United Kingdom | 2 |
| Ireland | 2 |
| Israel | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 17 |
| Finance | 9 |
| Commercial Services | 5 |
Operational
| Director/Board Member | 243 |
| Corporate Officer/Principal | 172 |
| Independent Dir/Board Member | 78 |
| Undergraduate Degree | 78 |
| Director of Finance/CFO | 48 |
Most connected contacts
| Insiders | |
|---|---|
| Julie McHugh | 26 |
| Ivan Philip Gergel | 24 |
| David P. Holveck | 22 |
| Peter Frank Drake | 22 |
| Andrew McDonald | 19 |
| David Meeker | 19 |
| David Southwell | 19 |
| Kevin Tang | 18 |
| George Migausky | 18 |
| Tim Mayleben | 18 |
| Saiid Zarrabian | 18 |
| Michael Martin | 17 |
| Pedro Granadillo | 16 |
| Joseph Edelman | 16 |
| Peter Hawryluk | 15 |
- Stock Market
- Insiders
- Rod Wong
- Company connections
